IMARC Group's report titled "Insomnia Market Report by Therapy Type (Non-Pharmacological Therapy, Pharmacological Therapy), Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Region 2024-2032". offers a comprehensive analysis of the industry, which comprises insights on the global insomnia market trends. The global market size reached US$ 5.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 2.69% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/insomnia-market/requestsample
Factors Affecting the Growth of the Insomnia Industry:
Increasing Stress Levels:
High levels of stress can cause sleep disturbances, making it difficult for individuals to fall asleep or stay asleep throughout the night. This is leading to an increasing likelihood of developing insomnia. Prolonged exposure to chronic stress can result in persistent sleep problems. Individuals experiencing chronic stress are seeking medical help for their sleep issues, catalyzing the demand for insomnia treatments. Stress can cause anxiety and depression, both of which are risk factors for insomnia. The psychological toll of stress can lead individuals to seek therapy or medication to address their sleep difficulties.
Aging Population:
Insomnia is more common among older adults. As the global population is aging, there is a higher overall prevalence of sleep disorders, including insomnia, which leads to a greater demand for treatment and management solutions. Aging is associated with changes in sleep patterns and sleep architecture. Older individuals often experience difficulties falling asleep, staying asleep, and maintaining deep sleep, which can contribute to the development or exacerbation of insomnia. Elderly individuals are more likely to have comorbid medical conditions, such as chronic pain, arthritis, and mental health disorders, which can increase the risk of insomnia.
Technological Advancements:
Technological innovations are giving rise to wearable devices and smartphone applications that can track and monitor sleep patterns. These devices provide individuals with insights into their sleep quality and can detect issues like insomnia. As a result, more people are motivated to seek solutions for their sleep problems. Telemedicine and remote health monitoring technologies enable healthcare providers to assess and diagnose sleep disorders, including insomnia, without requiring in-person visits. This makes it easier for individuals to access medical advice and treatment recommendations.
Leading Companies Operating in the Global Insomnia Industry:
Astellas Pharma Inc.
Aurobindo Pharma Limited
Biocodex
Eisai Co. Ltd.
Mallinckrodt Pharmaceuticals
Merck & Co. Inc.
Neurim Pharmaceuticals Inc.
Pfizer Inc.
Sanofi S.A.
Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
Takeda Pharmaceutical Company Limited
Vanda Pharmaceuticals Inc.
Insomnia Market Report Segmentation:
By Therapy Type:
Non-Pharmacological Therapy
Hypnotherapy
Cognitive Behavioral Therapy
Medical Devices
Others
Pharmacological Therapy
Prescription Sleep Aids
Over-The-Counter Sleep Aids
Pharmacological therapy represented the largest segment as pharmaceutical medications are often the initial choice for treating insomnia, offering quick relief for individuals with sleep difficulties.
By Drug Class:
Antidepressants
Melatonin Antagonist
Benzodiazepines
Nonbenzodiazepines
Orexin Antagonist
Others
Benzodiazepines accounted for the largest market share due to their widespread use in insomnia treatment, as they are known for their sedative properties and ability to induce sleep in patients with sleep disorders.
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Based on the distribution channel, the market has been divided into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
North America enjoys the leading position in the insomnia market on account of the high prevalence of sleep disorders, greater awareness, and access to healthcare services.
Global Insomnia Market Trends:
The prevalence of insomnia is increasing, driven by factors like stress, lifestyle changes, and an aging population, leading to a growing market for insomnia treatments and management solutions.
Ongoing technological innovations are resulting in the development of sleep-tracking devices, mobile apps, and digital therapies, providing individuals with tools to monitor and improve their sleep.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Comentários